Position in AMGN
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$9,400,273
+$658,208 QoQ
Shares Held
25,959
+4.5% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#570
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Welch & Forbes LLC holds $565,568,902 across 11 Drug Manufacturers - General names. AMGN ranks #6 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
172,704 | $207,146,375 | |
| 2 | JNJ |
Johnson & Johnson
|
657,989 | $167,109,466 | |
| 3 | ABBV |
AbbVie Inc.
|
345,978 | $87,061,903 | |
| 4 | MRK |
Merck & Co., Inc.
|
316,952 | $40,728,332 | |
| 5 | GSK |
GSK plc
|
518,597 | $27,184,854 | |
| 6 | AMGN |
Amgen Inc
This page
|
25,959 | $9,400,273 | |
| 7 | NVS |
Novartis AG
|
57,984 | $9,087,252 | |
| 8 | PFE |
Pfizer Inc
|
341,080 | $8,213,206 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,400,273 | 25,959 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $8,742,065 | 24,846 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $8,160,165 | 24,931 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $7,099,023 | 25,156 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $7,101,427 | 25,434 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $7,827,693 | 25,125 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $6,678,900 | 25,625 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $8,234,076 | 25,555 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $8,100,266 | 25,925 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $7,381,515 | 25,962 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $7,392,321 | 25,666 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $6,902,025 | 25,681 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $6,363,759 | 28,663 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $6,962,400 | 28,800 | Shares | Sole | 2023-04-14 | |
| 2022-12-31 | $7,668,300 | 29,197 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $6,598,810 | 29,276 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $7,410,918 | 30,460 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $7,537,771 | 31,171 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $7,037,286 | 31,281 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $7,421,059 | 34,898 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $8,852,756 | 36,319 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $8,946,958 | 35,959 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $8,600,847 | 37,408 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $9,617,414 | 37,840 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $9,080,374 | 38,499 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $8,120,755 | 40,057 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||